JANE WANG: Open Payments
NPI 1376694919 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 9 payments from 3 companies in 2025. Trend: 2023 $384 · 2024 $401 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $361 |
| Gilead Sciences, Inc. | 1 | $127 |
| GlaxoSmithKline, LLC. | 2 | $78 |
Products named: TEZSPIRE, FASENRA, NUCALA.
Industry payments across CA — which companies pay providers there.
